Team:Slovenia

From 2008.igem.org

(Difference between revisions)
 
(112 intermediate revisions not shown)
Line 1: Line 1:
-
<!-- *** What falls between these lines is the Alert Box!  You can remove it from your pages once you have read and understood the alert *** -->
+
<html>
 +
<head>
 +
<link rel="stylesheet" type="text/css" href="http://www.obrazuspeha.si/css_igem_slo08/default.css">
 +
<!-- dd menu -->
 +
<script type="text/javascript">
 +
<!--
 +
var timeout        = 500;
 +
var closetimer = 0;
 +
var ddmenuitem      = 0;
 +
 +
// open hidden layer
 +
function mopen(id)
 +
{
 +
// cancel close timer
 +
mcancelclosetime();
 +
 +
// close old layer
 +
if(ddmenuitem) ddmenuitem.style.visibility = 'hidden';
 +
 +
// get new layer and show it
 +
ddmenuitem = document.getElementById(id);
 +
ddmenuitem.style.visibility = 'visible';
 +
 +
}
 +
// close showed layer
 +
function mclose()
 +
{
 +
if(ddmenuitem) ddmenuitem.style.visibility = 'hidden';
 +
}
 +
 +
// go close timer
 +
function mclosetime()
 +
{
 +
closetimer = window.setTimeout(mclose, timeout);
 +
}
 +
 +
// cancel close timer
 +
function mcancelclosetime()
 +
{
 +
if(closetimer)
 +
{
 +
window.clearTimeout(closetimer);
 +
closetimer = null;
 +
}
 +
}
 +
 +
// close layer when click-out
 +
document.onclick = mclose;
 +
// -->
 +
</script>
 +
 +
</head>
 +
 +
</html>
 +
<!------------------------------- ZACETEK IGEM 2008 STRANI ------------------------------------------------------>
<html>
<html>
-
<!--<div id="box" style="width: 700px; margin-left: 137px; padding: 5px; border: 3px solid #000; background-color: #fe2b33;">
+
<table border="0" cellspacing="0" cellpadding="0" width="80%" align="center" >
-
<div id="template" style="text-align: center; font-weight: bold; font-size: large; color: #f6f6f6; padding: 5px;">
+
<tr>
-
This is a template page. READ THESE INSTRUCTIONS.
+
<td>
-
</div>
+
<!-- Zacetek slike logo -->
-
<div id="instructions" style="text-align: center; font-weight: normal; font-size: small; color: #f6f6f6; padding: 5px;">
+
</html>
-
You are provided with this team page template with which to start the iGEM season.  You may choose to personalize it to fit your team but keep the same "look." Or you may choose to take your team wiki to a different level and design your own wiki.  You can find some examples <a href="https://2008.igem.org/Help:Template/Examples">HERE</a>.
+
[[Image:Igem-logo-900x200-1-2.jpg|900px|center]]
-
</div>
+
<html>
-
<div id="warning" style="text-align: center; font-weight: bold; font-size: small; color: #f6f6f6; padding: 5px;">
+
<!-- konec slike logo -->
-
You <strong>MUST</strong> have a team description page, a project abstract, a complete project description, and a lab notebook.  PLEASE keep all of your pages within your Team:Example namespace. 
+
</td>
-
</div>
+
</tr>
-
</div>-->
+
<tr>
 +
<td>
 +
<!-- zacetek meni-ja -->
 +
<center>
 +
<div align="center" style="width:900px; background-color:#528e68; text-align:center;"><!--<img src="https://static.igem.org/mediawiki/2008/0/05/IGEM-Slovenia_btn_v2_1.gif" align="center" width="900" height="30" border="0" usemap="#Map" />-->
 +
<ul id="sddm">
 +
<li><a href="https://2008.igem.org/Team:Slovenia" target="_self" ><img src="https://static.igem.org/mediawiki/2008/b/b7/Home_btn.gif" width="64" height="30" border="0" /></a></li>
 +
<li><a href="https://2008.igem.org/Team:Slovenia/Background" target="_self" onmouseover="mopen('m1')" onmouseout="mclosetime()"><img src="https://static.igem.org/mediawiki/2008/c/ca/Background_btn.gif" width="138" height="30" border="0" /></a>
 +
<div id="m1" onmouseover="mcancelclosetime()" onmouseout="mclosetime()">
 +
<a href="https://2008.igem.org/Team:Slovenia/Background/The_problem" target="_self">The problem</a>
 +
<a href="https://2008.igem.org/Team:Slovenia/Background/Modern_vaccines" target="_self">Modern vaccines</a>
 +
<a href="https://2008.igem.org/Team:Slovenia/Background/Immune_response" target="_self">Immune response</a>
 +
<a href="https://2008.igem.org/Team:Slovenia/Background/Flagellin" target="_self">Flagellin</a>
 +
</div>
 +
</li>
 +
<li><a href="https://2008.igem.org/Team:Slovenia/Project" target="_self" onmouseover="mopen('m2')" onmouseout="mclosetime()"><img src="https://static.igem.org/mediawiki/2008/2/23/Project_btn.gif" width="138" height="30" border="0" /></a>
 +
<div id="m2" onmouseover="mcancelclosetime()" onmouseout="mclosetime()">
 +
<a href="https://2008.igem.org/Team:Slovenia/Project/Motivation" target="_self">Motivation</a>
 +
<a href="https://2008.igem.org/Team:Slovenia/Project/Engineered_flagellin_vaccine" target="_self">Engineered flagellin vaccine</a>
 +
<a href="https://2008.igem.org/Team:Slovenia/Project/Antigen-TLR_fusion_vaccine" target="_self">Antigen-TLR fusion vaccine</a>
 +
</div>
 +
</li>
 +
<li><a href="https://2008.igem.org/Team:Slovenia/Results" target="_self" onmouseover="mopen('m3')" onmouseout="mclosetime()"><img src="https://static.igem.org/mediawiki/2008/4/49/Results_btn.gif" width="96" height="30" border="0" /></a>
 +
<div id="m3" onmouseover="mcancelclosetime()" onmouseout="mclosetime()">
 +
<a href="https://2008.igem.org/Team:Slovenia/Results/Engineered_flagellin_vaccine" target="_self">Engineered flagellin vaccine</a>
 +
<a href="https://2008.igem.org/Team:Slovenia/Results/Antigen-TLR_fusion_vaccine" target="_self">Antigen-TLR fusion vaccine</a>
 +
<a href="https://2008.igem.org/Team:Slovenia/Results/Real-life_results" target="_self">"Real-life" results</a>
 +
<a href="https://2008.igem.org/Team:Slovenia/Results/Biobricks" target="_self">Biobricks</a>
 +
</div>
 +
</li>
 +
<!-- tukaj je slika menija conclusion -->
 +
<li><a href="https://2008.igem.org/Team:Slovenia/Conclusions" target="_self" ><img src="https://static.igem.org/mediawiki/2008/b/bd/Biobricks_btn.gif" width="138" height="30" border="0" /></a></li>
 +
<!-- konec slike menija conclusion -->
 +
<li><a href="https://2008.igem.org/Team:Slovenia/Notebook" target="_self" onmouseover="mopen('m4')" onmouseout="mclosetime()"><img src="https://static.igem.org/mediawiki/2008/8/8e/Notebook_btn.gif" width="114" height="30" border="0" /></a>
 +
<div id="m4" onmouseover="mcancelclosetime()" onmouseout="mclosetime()">
 +
<a href="https://2008.igem.org/Team:Slovenia/Notebook/Methods" target="_self">Methods</a>
 +
<a href="https://2008.igem.org/Team:Slovenia/Notebook/Safety" target="_self">Safety</a>
 +
<a href="https://2008.igem.org/Team:Slovenia/Notebook/References" target="_self">References</a>
 +
                <a href="https://2008.igem.org/Team:Slovenia/Notebook/Notebook" target="_self">Notebook</a>
 +
</div>
 +
</li>
 +
 +
 +
<li><a href="https://2008.igem.org/Team:Slovenia/Team" target="_self" ><img src="https://static.igem.org/mediawiki/2008/7/73/Team_btn.gif" width="109" height="30" border="0" /></a></li>
 +
 +
 +
<li><a href="https://2008.igem.org/Team:Slovenia/Credits" target="_self" onmouseover="mopen('m5')" onmouseout="mclosetime()"><img src="https://static.igem.org/mediawiki/2008/d/d4/Sponsors_btn.gif" width="103" height="30" border="0" /></a>
 +
<div id="m5" onmouseover="mcancelclosetime()" onmouseout="mclosetime()">
 +
<a href="https://2008.igem.org/Team:Slovenia/Acknowledgements" target="_self">Acknowledgements</a>
 +
<a href="https://2008.igem.org/Team:Slovenia/Sponsors" target="_self">Sponsors</a>
 +
</div>
 +
</li>
 +
</ul>
 +
<div style="clear:both"></div>
 +
 +
<div style="clear:both"></div>
 +
</div>
 +
</center>
 +
<!-- konec menija -->
 +
<td>
 +
</tr>
 +
<tr>
 +
<td align="center">
 +
<p style="font-family:Verdana; font-size:12px;"><br /><br />
</html>
</html>
 +
<!-- #################################################
 +
######################################################
-
<!-- Zacetek slike logo -->
+
PROSTOR ZA NASLOV JE PRIPRAVLJEN ZA ZNAKOM (minus minus je večje). V 5.vrstici od trenutne!
-
[[Image:Igem-logo-900x200-1-2.jpg|900px|center]]
+
#################################################
 +
######################################################
 +
-->
-
<!-- konec slike logo -->
+
<html>
 +
</p>
 +
</td>
 +
</tr>
 +
<tr>
 +
<td align="justify">
 +
<p>
 +
</html>
 +
<!-- #################################################
 +
######################################################
-
<!-- zacetek meni -->
+
PROSTOR ZA TEKST JE PRIPRAVLJEN ZA ZNAKOM (minus minus je večje). V 6.vrstici od trenutne!
-
<html><img src="Igem gumbi2.jpg" width="900" height="30" border="0" usemap="#Map" /></html>
+
-
<!-- konec meni -->
+
-
<!-- *** End of the alert box *** -->
+
#################################################
 +
######################################################
 +
-->
 +
<html><center>
 +
<font size="8" color="#C73E4A"><i>Immunobricks</i></font><br>
 +
<br>
 +
</center></html>
 +
----
-
<!--{|align="justify"
 
-
|You can write a background of your team here.  Give us a background of your team, the members, etc.  Or tell us more about something of your choosing.
 
-
|[[Image:Example_logo.png|200px|right|frame]]
 
-
|-
 
-
|
 
-
''Tell us more about your project.  Give us background.  Use this is the abstract of your project.  Be descriptive but concise (1-2 paragraphs)''
 
-
|[[Image:Team.png|right|frame|Your team picture]]
 
-
|-
 
-
|
 
-
|align="center"|[[Team:Slovenia | Team Example 2]]
 
-
|}-->
 
-
<!--- The Mission, Experiments --->
 
<html>
<html>
-
<a href="http://www4.clustrmaps.com/counter/maps.php?url=https://2008.igem.org/Team:Slovenia" id="clustrMapsLink"><img src="http://www4.clustrmaps.com/counter/index2.php?url=https://2008.igem.org/Team:Slovenia" style="border:0px;" alt="Locations of visitors to this page" title="Locations of visitors to this page" id="clustrMapsImg" onerror="this.onerror=null; this.src='http://www2.clustrmaps.com/images/clustrmaps-back-soon.jpg'; document.getElementById('clustrMapsLink').href='http://www2.clustrmaps.com';" />
+
 
-
</a>
+
 
 +
</div></center>
 +
<table>
 +
<tr >
 +
<td bgcolor="#e3efe7" align="justify" >
 +
<strong>Abstract for non-specialists</strong><br /><br />
 +
<div style="text-align:justify;">Bacteria <i><b>Helicobacter pylori</b></i> infects half of the world population causing gastritis and contributing to increased incidence of ulcers and gastric malignancies. This infection can be treated with multi-drug regime, but this is often associated with induced antibiotic resistance and does not protect individuals from re-infections. Vaccination against <i>H. pylori</i> can therefore be a viable alternative to control this widespread infection. However, developing an effective vaccine against <i>H. pylori</i> has presented a challenge because <i>H. pylori</i> or its components, which have frequently been used as parts of vaccines, are modified by bacteria such that they evade host defense mechanisms. Using synthetic biology approaches we managed to assemble functional <b>“immunobricks”</b> into a <b>designer vaccine</b> with a goal to activate both innate and acquired immune response to <i>H. pylori</i>. We successfully developed two forms of such designer vaccines. One was based on modifying <i>H. pylori</i> component (flagellin) such that it can now be recognized by the immune system. The other relied upon linking <i>H. pylori</i> components to certain molecules of the innate immune response (so called Toll-like receptors) to activate and guide <i>H. pylori</i> proteins to relevant compartments within the immune cell causing optimal innate and acquired immune response. Both types of vaccines have been thoroughly characterized in vitro (in test tubes or cells) as well as in vivo (laboratory mice) exhibiting substantial antibody response. Our strategy of both vaccines’ design is not limited to <i>H. pylori</i> and can be applied to other pathogens. Additionally, our vaccines can be delivered using simple and inexpensive vaccination routes, which could be suitable also in third world countries.</div>
 +
</td>
 +
</tr>
 +
<tr><td>&nbsp;</td></tr>
 +
<tr>
 +
<td bgcolor="#cbcdcb" align="justify">
 +
<strong>Scientific abstract</strong><br />
 +
<br />
 +
<div style="text-align:justify;">Almost half of the world's population is infected with bacteria <i>Helicobacter pylori</i>, which colonize gastric mucosa, causing gastritis and ulcers and is recognized as a type I carcinogen by WHO. An <b>effective vaccine against <i>H. pylori</i> is not available</b>, although it would be a durable solution, particularly in a formulation affordable to the third world population. <i>H. pylori</i> evades the immune surveillance by modifying several of its components including flagellin to avoid detection by several Toll-like receptors.
 +
 
 +
The goal of our project was to <b>prepare a modular designer vaccine, using the principles of synthetic immunology</b>. An effective vaccine has to trigger activation of adaptive immunity, which is directed against microbial proteins or polysaccharides as well as of innate immunity, which is usually achieved by the addition of adjuvants of whole microbes. We prepared a <b>set of “immunobricks”</b> with defined functions in activation of the immune system and can be combined to achieve a desired response.
 +
 
 +
In the first approach we have <b>modified <i>H. pylori</i> flagellin</b> to be able to activate TLR5, <b>making it »visible«</b> to the immune system. To this chimeric flagellin we attached either complete protein or a designed a <b>multiepitope of several virulence factors of <i>H. pylori</i></b>. We prepared <b>three implementations</b> of this system in the form of recombinant proteins, engineered bacteria and DNA vaccines, demonstrated responsiveness of each of them in cell culture assays, cellular localization and even obtained significant antibody response in laboratory animals only weeks after vaccination.
 +
 
 +
The second approach was to extend the range of activation of innate immune response to different Toll-like receptors by <b>linking antigen to different TLR segments, which are constitutively activated</b> by the addition of a dimerization domain. In this case we could direct localization of resulting fusion receptors to either cell membrane or cellular vesicles, which should assist in proper antigen processing and presentation. The power of this approach is that <b>we could mimic synergistic activation of several TLRs by pathogenic microbes, while having the advantage of safety of a defined subunit vaccine</b>.</div>
 +
</td>
 +
</tr>
 +
</table>
</html>
</html>
 +
-
{| style="color:#1b2c8a;background-color:#0c6;" cellpadding="3" cellspacing="1" border="1" bordercolor="#fff" width="62%" align="center"
+
<html><center><img src="https://static.igem.org/mediawiki/2008/0/0e/ImplementationOfChimericFlagell.gif" width="800" height="597" border="0" /></center></html>
-
!align="center"|[[Team:Slovenia|Home]]
+
 
-
!align="center"|[[Team:Slovenia/Team|The Team]]
+
<html><center>
-
!align="center"|[[Team:Slovenia/Project|The Project]]
+
Experimental work on this project was performed by seven undergraduate students between june and october 2008, supported by their mentors.</center>
-
!align="center"|[[Team:Slovenia/Parts|Parts Submitted to the Registry]]
+
</html>
-
!align="center"|[[Team:Slovenia/Modeling|Modeling]]
+
 
-
!align="center"|[[Team:Slovenia/Notebook|Notebook]]
+
 
-
|}
+
----
-
(''Or you can choose different headings. But you must have a team page, a project page, and a notebook page.'')
+
<html><center> <a href="http://www.ki.si/raziskovalne-enote/l12-laboratorij-za-biotehnologijo/"><font="24"> Department of Biotechnology
 +
<br>National Institute of Chemistry, Slovenia </a>
 +
 
 +
</html>
 +
 
 +
<html>
 +
</p>
 +
</td>
 +
</tr>
 +
<tr>
 +
<td align="center">
 +
<br /><br />
 +
<a href="http://www4.clustrmaps.com/counter/maps.php?url=https://2008.igem.org/Team:Slovenia" id="clustrMapsLink"><img src="http://www4.clustrmaps.com/counter/index2.php?url=https://2008.igem.org/Team:Slovenia" style="border:0px;" alt="Locations of visitors to this page" title="Locations of visitors to this page" id="clustrMapsImg" onerror="this.onerror=null; this.src='http://www2.clustrmaps.com/images/clustrmaps-back-soon.jpg'; document.getElementById('clustrMapsLink').href='http://www2.clustrmaps.com';" />
 +
</a>
 +
</td>
 +
</tr>
 +
</table>
 +
<map name="Map" id="Map">
 +
<area shape="rect" coords="795,3,896,28" href="https://2008.igem.org/Team:Slovenia/Sponsors" target="_self" />
 +
<area shape="rect" coords="66,-1,176,29" href="https://2008.igem.org/Team:Slovenia/Team" target="_self" />
 +
<area shape="rect" coords="326,3,461,29" href="https://2008.igem.org/Team:Slovenia/Project" target="_self" />
 +
<area shape="rect" coords="466,3,559,28" href="https://2008.igem.org/Team:Slovenia/Results" target="_self" />
 +
<area shape="rect" coords="564,3,672,27" href="https://2008.igem.org/Team:Slovenia/Biobricks" target="_self" />
 +
<area shape="rect" coords="678,2,789,28" href="https://2008.igem.org/Team:Slovenia/Notebook" target="_self" />
 +
<area shape="rect" coords="2,2,60,29" href="https://2008.igem.org/Team:Slovenia" target="_self" />
 +
<area shape="rect" coords="181,1,323,28" href="https://2008.igem.org/Team:Slovenia/Background" target="_self" />
 +
</map>
 +
</html>
 +
<!------------------------------- KONEC IGEM 2008 STRANI ------------------------------------------------------>

Latest revision as of 15:01, 12 December 2008

Igem-logo-900x200-1-2.jpg



Immunobricks




Abstract for non-specialists

Bacteria Helicobacter pylori infects half of the world population causing gastritis and contributing to increased incidence of ulcers and gastric malignancies. This infection can be treated with multi-drug regime, but this is often associated with induced antibiotic resistance and does not protect individuals from re-infections. Vaccination against H. pylori can therefore be a viable alternative to control this widespread infection. However, developing an effective vaccine against H. pylori has presented a challenge because H. pylori or its components, which have frequently been used as parts of vaccines, are modified by bacteria such that they evade host defense mechanisms. Using synthetic biology approaches we managed to assemble functional “immunobricks” into a designer vaccine with a goal to activate both innate and acquired immune response to H. pylori. We successfully developed two forms of such designer vaccines. One was based on modifying H. pylori component (flagellin) such that it can now be recognized by the immune system. The other relied upon linking H. pylori components to certain molecules of the innate immune response (so called Toll-like receptors) to activate and guide H. pylori proteins to relevant compartments within the immune cell causing optimal innate and acquired immune response. Both types of vaccines have been thoroughly characterized in vitro (in test tubes or cells) as well as in vivo (laboratory mice) exhibiting substantial antibody response. Our strategy of both vaccines’ design is not limited to H. pylori and can be applied to other pathogens. Additionally, our vaccines can be delivered using simple and inexpensive vaccination routes, which could be suitable also in third world countries.
 
Scientific abstract

Almost half of the world's population is infected with bacteria Helicobacter pylori, which colonize gastric mucosa, causing gastritis and ulcers and is recognized as a type I carcinogen by WHO. An effective vaccine against H. pylori is not available, although it would be a durable solution, particularly in a formulation affordable to the third world population. H. pylori evades the immune surveillance by modifying several of its components including flagellin to avoid detection by several Toll-like receptors. The goal of our project was to prepare a modular designer vaccine, using the principles of synthetic immunology. An effective vaccine has to trigger activation of adaptive immunity, which is directed against microbial proteins or polysaccharides as well as of innate immunity, which is usually achieved by the addition of adjuvants of whole microbes. We prepared a set of “immunobricks” with defined functions in activation of the immune system and can be combined to achieve a desired response. In the first approach we have modified H. pylori flagellin to be able to activate TLR5, making it »visible« to the immune system. To this chimeric flagellin we attached either complete protein or a designed a multiepitope of several virulence factors of H. pylori. We prepared three implementations of this system in the form of recombinant proteins, engineered bacteria and DNA vaccines, demonstrated responsiveness of each of them in cell culture assays, cellular localization and even obtained significant antibody response in laboratory animals only weeks after vaccination. The second approach was to extend the range of activation of innate immune response to different Toll-like receptors by linking antigen to different TLR segments, which are constitutively activated by the addition of a dimerization domain. In this case we could direct localization of resulting fusion receptors to either cell membrane or cellular vesicles, which should assist in proper antigen processing and presentation. The power of this approach is that we could mimic synergistic activation of several TLRs by pathogenic microbes, while having the advantage of safety of a defined subunit vaccine.


Experimental work on this project was performed by seven undergraduate students between june and october 2008, supported by their mentors.



Department of Biotechnology
National Institute of Chemistry, Slovenia



Locations of visitors to this page